v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Consolidated net income $ 2,329 $ 1,967
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation, depletion, amortization and accretion 2,304 2,199
Deferred income tax expense (benefit) 196 241
Provision for bad debts 96 61
Equity-based compensation expense 139 135
Net gain on disposal of assets (8) (14)
(Gain) loss from divestitures, asset impairments and other, net 2 239
Change in operating assets and liabilities, net of effects of acquisitions and divestitures:    
Receivables (389) (453)
Other current assets (7) (75)
Other assets 203 165
Accounts payable and accrued liabilities 194 35
Deferred revenues and other liabilities (192) (155)
Net cash provided by operating activities 4,867 4,345
Cash flows from investing activities:    
Acquisitions of businesses, net of cash acquired (89) (395)
Capital expenditures (1,937) (2,339)
Proceeds from divestitures of businesses and other assets, net of cash divested 79 108
Other, net (112) (73)
Net cash used in investing activities (2,059) (2,699)
Cash flows from financing activities:    
New borrowings 18,644 14,956
Debt repayments (18,668) (15,772)
Common stock repurchase program (1,583) 0
Cash dividends (1,141) (1,001)
Exercise of common stock options 41 54
Tax payments associated with equity-based compensation transactions (40) (50)
Other, net (19) (17)
Net cash used in financing activities (2,766) (1,830)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents (7) 5
Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents 35 (179)
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period 297 487
Cash, cash equivalents and restricted cash and cash equivalents at end of period $ 332 $ 308